Author/Authors :
Abtahi Shabnam نويسنده Department of Pediatric Surgery, Pediatric Medical Center, Tehran University of Medical Sciences, Tehran, Iran , Ahmadi Jamshid نويسنده Substance Abuse Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract :
Introduction Buprenorphine is used to treat opioid use disorder
and pain syndromes. This drug may be a suitable treatment choice for
refractory depression, anxiety, self-injurious behaviors, and suicidal
ideation. However, it has a significant abuse potential, which limits
its use in suicidal patients with a history of substance abuse. Case
Report In this report, we present a case of chronic suicidal ideation
due to substance-induced depressive disorder in a 25-year-old man from
Noorabad, Fars, Iran. The patient was successfully treated with an 8-mg
single dose of sublingual buprenorphine with minimal probability of
diversion or misuse. We observed that 8 mg of buprenorphine exerted a
rapid effect on the reduction and cessation of suicidal thoughts and
depression. Conclusions We demonstrated the antisuicidal effectiveness
of a single dose of buprenorphine, which can be administered with
minimum risk of diversion or misuse for suicidal patients with a history
of substance abuse.